Quantum Health is one of the biggest and original navigation companies. Dayne Williams came out of retirement to take over as CEO after Zane Burke retired for personal reasons (to care for a relative). Quantum has in recent months added two acquisitions, Embold Health that analyzes which are the best doctors to go to, and…
At the annual Medicarians conference in Las Vegas that draws brokers, agents, agency owners and field marketing organizations, among others, Dawn Maroney suggested that payers are not always the “bad guys.” The post Alignment Health Plan CEO: Sometimes When MA Plan is Pulling Out, the Provider is to Blame appeared first on MedCity News.
Oscar Health launched Lucie, a marketplace aimed at making healthcare more shoppable. The post Oscar Health Seeks to Build ‘Airbnb for Healthcare’ with New Marketplace, CEO Says appeared first on MedCity News.
The initiative funds diverse research teams exploring digital, neuromodulation, and psychedelic therapies to improve mental health outcomes
Advancements in AI and data analytics are seen as promising tools to identify at-risk individuals
The initiative aims to foster better medical practice sharing among VA facilities
Tortugas Neurosciences’ two lead programs are in-licensed oral small molecules in development for schizophrenia and tinnitus. The startup is led by veterans of Sage Therapeutics, a neuroscience biotech that was acquired last year. The post Neuro Startup Tortugas Unveils $106M and a Pipeline of Drugs for the Brain appeared first on MedCity News.
By using AI-powered intelligence to shift clinical and coding validation earlier in the healthcare continuum, and unlocking upstream clinical data to inform downstream payment workflows, organizations can proactively prevent errors, reduce downstream churn and friction, and support more predictable, accurate, and timely payments. The post The Next Era of Payment Integrity: Earlier Clinical Validation, True…
What matters just as much — if not more — is everything around that number: how customers adopt the product, how sales actually happen, and whether the company is building something that can scale inside a complex, regulated system. The post Revenue Isn’t the Signal: What Early-Stage Health Tech Investors Should Be Watching Instead appeared…
To kick off KFF’s Business of Health with Chip Kahn, KFF’s Drew Altman explains how KFF is continually evolving to research, analyze and lead on health policy. Chip and Drew discuss how KFF’s new podcast will break down the business side of health care, artificial intelligence, and what it all means for health care delivery…